RECENT NEWS

The Royal College of Pathologists (RCPath) has welcomed the publication of the Public Accounts Committee's report following its inquiry on antimicrobial resistance (AMR) and its recognition of the vital role of medical microbiology and virology.

The Institute of Biomedical Science has proclaimed Biomedical Science Day 2025 a huge success, with 320 events reaching thousands for the biggest celebratory day yet.

Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to advancing precision medicine. This perspective comes as organisations across the sector prioritise modernisation and seek trusted partners to support their transformation, according to new research.

Medical AI firm Paige has announced a new partnership with the Breast International Group (BIG), a leading international non-profit organisation dedicated to breast cancer research, to conduct collaborative research aimed at improving breast cancer diagnosis, treatment, and patient outcomes.

Cleanroom microbiology firm Cherwell has introduced a new range of plated prepared media designed to deliver sample security, data integrity, and optimised workflow in microbial monitoring.

The Royal College of Pathologists has launched a new Patient Safety Steering Group (PSSG), bringing together expert voices from across the profession to help implement the College’s Patient Safety and Quality Strategy 2024–2029.

A state-of-the-art centre has been opened that could help clinicians advance personalised medicine by understanding complex biological systems. The new Multi-Omics Research Laboratory at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust could also support the development of new diagnostic tests.

Linear Diagnostics has been awarded funding of £1 million to finalise the development of a rapid test for sexually transmitted infections (STIs), in partnership with the NIHR HealthTech Research Centre (HRC) in Diagnostic and Technology Evaluation and the North East Innovation Lab, part of Newcastle Hospitals.

More NHS patients will receive test results - along with appointment reminders and screening invitations - directly to their smartphones following a £50million upgrade to the NHS App which aims to make it easier for patients to access care.

Quantico, the diagnostic platform developed by Viscera Technologies, was the runner-up in the ‘Best Digital Health Solution’ category at the Prix Galien UK Awards, which were hosted at the Natural History Museum in London.

A technology project to support the transformation of pathology services across Northern Ireland has been completed, with the go-live of the Clinisys WinPath laboratory information management system (LIMS) at the final two health and social care trusts.

Diagnostics firm QuidelOrtho has announced a refocusing of its molecular diagnostics strategy, to include the full acquisition of LEX Diagnostics and discontinuing the company's Savanna platform development.

A new digital hub in Leeds is being launched by the Medicines and Healthcare products Regulatory Agency (MHRA), marking a significant step in the agency’s long-term commitment to advancing innovation and strengthening its presence across the UK.

On Thursday 5 June hospital laboratories across the UK marked Biomedical Science Day 2025 - a national celebration of the scientists and laboratory staff whose work underpins patient care.

Cytek Biosciences has announced the launch of the Cytek Aurora Evo system, a new full-spectrum flow cytometer that improves on its flagship Cytek Aurora system.

Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses which spans all stages of therapeutic development from discovery through to commercialisation, have announced new names and identities as part of a strategic positioning effort.

Researchers at US health group Mass General Brigham have developed a novel diagnostic tool which uses bioluminescence to more accurately identify viruses including SARS-CoV-2, HIV, HBV, and HCV in patient samples.

Genomics England researchers have played a key role in the development of a new artificial intelligence tool, known as SAVANA, that uses long-read sequencing data to find specific changes within a person’s DNA linked to cancer.

Danaher has announced the launch of a partnership with AstraZeneca to develop and commercialise novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.

Thousands of NHS patients with lung and breast cancer are to benefit from liquid biopsies, speeding up access to targeted therapy.